SCHEMBL1947010

SCHEMBL1947010

CCCCCCCCCCCCC(CCCCCCCCCCCC)(OP)C(O)CO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
LMNA P02545 5/20 0.36
MAPT P10636 3/20 0.35
CYP2D6 P10635 2/20 0.35
KDM4E B2RXH2 2/20 0.35
SPHK1 Q9NYA1 1/20 0.35
GMNN O75496 1/20 0.35
POLB P06746 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
BLM P54132 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CETP P11597 1/20 0.35
HTT P42858 1/20 0.35
UBE2N P61088 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
DUSP3 P51452 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7724764 1.00 USP2 (0.38) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL226512 1.00 USP2 (0.38) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL3802891 0.91 DGKA (0.43) LMNAMAPTCYP2D6KDM4ESPHK1
SCHEMBL11150089 0.85 USP2 (0.40) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL10357997 0.85 USP2 (0.40) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL4394710 0.83 USP2 (0.39) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL3807431 0.82 USP2 (0.37) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL4204713 0.80 USP2 (0.44) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL4204839 0.80 USP2 (0.44) USP2LMNAMAPTCYP2D6KDM4E
SCHEMBL303130 0.80 USP2 (0.44) USP2LMNAMAPTCYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734252-B1 VINCA-ALKALOID VESICLES WITH ENHANCED EFFICACY AND TUMOR TARGETING PROPERTIES NEXSTAR PHARMACEUTICALS INC (US) 2003-04-16 EP claimed
CN-109640951-B Preparation of microparticles of controlled size 博莱科瑞士股份有限公司 2023-08-25 CN disclosed
US-20130108688-A1 Delivery of H2 Antagonists TRUSTEES OF BOSTON UNIVERSITY (US) 2013-05-02 US disclosed
US-20110135716-A1 DELIVERY OF H2 ANTAGONISTS TRUSTEES OF BOSTON UNIVERSITY (US) 2011-06-09 US disclosed
US-20080045575-A1 Delivery of H2 Antagonists ZARZATECH, INC. 2008-02-21 US disclosed